Screener
Inhibrx Biosciences, Inc. INBX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | MARCH 31, 2026 | DECEMBER 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $161,657 | $124,220 |
| Other receivables | 186 | 177 |
| Prepaid expenses and other current assets | 9,498 | 8,435 |
| Total current assets | 171,341 | 132,832 |
| Property and equipment, net | 3,196 | 3,733 |
| Operating right-of-use asset | 5,052 | 5,535 |
| Other non-current assets | 4,378 | 4,378 |
| Total assets | $183,967 | $146,478 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s total current assets?
- Inhibrx Biosciences, Inc. (INBX) reported total current assets of $171.34M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s total current assets changed year-over-year?
- Inhibrx Biosciences, Inc.'s total current assets decreased by 23.3% year-over-year, from $223.39M to $171.34M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s total current assets?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s total current assets has grown at a -32.9% compound annual growth rate (CAGR), from $295.36M to $132.83M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Inhibrx Biosciences, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude